Andrews Liver Salts Effervescent Powder
*Company:
Haleon Ireland LimitedStatus:
DiscontinuedLegal Category:
Supply through general saleActive Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 30 May 2025
File name
MASTER-ie-text-pil-andrews-IE03 MAH-implemented 19May2025.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Free text change information supplied by the pharmaceutical company
The marketing authorisation holder is
Haleon Ireland Limited, Clocherane, Dungarvan, Co. Waterford, Ireland.
Updated on 30 May 2025
File name
MASTER-ie-spc-andrews-IE03 MAH-implemented 19May2025.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Legal category:Supply through general sale
Free text change information supplied by the pharmaceutical company
7 MARKETING AUTHORISATION HOLDER
Haleon Ireland Limited
Clocherane,
Youghal Road,
Dungarvan,
Co. Waterford,
X35 Y983,
Ireland.
Updated on 27 June 2023
File name
Master-ie-pil-andrews_-Approved 20June2023.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
Free text change information supplied by the pharmaceutical company
Update to section 6 MAH now Haleon Ireland Limited12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
Updated on 27 June 2023
File name
MASTER-ie-spc-andrews--appoved 20June2023.pdf
Reasons for updating
- New SPC for new product
Legal category:Supply through general sale
Free text change information supplied by the pharmaceutical company
Update to MAH in Section 7 to Haleon
Update to Revision of text in Section 10
Updated on 09 January 2023
File name
MASTER-ie-spc-andrews-678-043-001-approved-July2015.pdf
Reasons for updating
- Document format updated
Legal category:Supply through general sale
Updated on 03 May 2016
File name
PIL_9241_862.pdf
Reasons for updating
- New PIL for new product
Updated on 03 May 2016
Reasons for updating
- Change to MA holder contact details
Updated on 10 July 2015
Reasons for updating
- New SPC for new product
Legal category:Supply through general sale
Updated on 10 July 2015
Reasons for updating
- Change to section 7 - Marketing authorisation holder
Legal category:Supply through general sale
Free text change information supplied by the pharmaceutical company
Section 7
Marketing Authorisation Holder address updated to:
12 Riverwalk,
Citywest Business Campus,
Dublin 24,
Ireland
Updated on 22 May 2015
Reasons for updating
- Change to Section 4.8 – Undesirable effects - how to report a side effect
Legal category:Supply through general sale
Free text change information supplied by the pharmaceutical company
Updated on 21 May 2015
Reasons for updating
- Change to side-effects
Updated on 03 December 2012
Reasons for updating
- Change due to harmonisation of PIL
Updated on 13 August 2010
Reasons for updating
- Change to warnings or special precautions for use
- Change of contraindications
- Change to information about pregnancy or lactation
Updated on 24 August 2009
Reasons for updating
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
Legal category:Supply through general sale
Free text change information supplied by the pharmaceutical company
Section 4.4: Addition of warning re sugar intolerances.
Section 4.6: Addition of warnings re pergnancy.
Updated on 20 February 2009
Reasons for updating
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
Legal category:Supply through general sale
Free text change information supplied by the pharmaceutical company
This product should not be given to patients with a hypersensitivity to any component of Andrews Liver Salts or any previous hypersensitivity to Andrews Liver Salts.
Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
Updated on 28 August 2007
Reasons for updating
- Improved electronic presentation
Updated on 30 May 2007
Reasons for updating
- Improved electronic presentation
Updated on 22 May 2007
Reasons for updating
- Change to section 6.5 - Nature and contents of container
Legal category:Supply through general sale
Free text change information supplied by the pharmaceutical company
6.5 Nature and Contents of Container
Removal of reference to 'integral 5 ml spoon'
Updated on 20 April 2007
Reasons for updating
- Change to section 1 - Name of medicinal product
- Change to section 6.4 - Special precautions for storage
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category:Supply through general sale
Free text change information supplied by the pharmaceutical company
1. Name of the medicinal product
Change name to: Andrews Liver Salts Effervescent Powder
6.4 Special Precautions for Storage
Amend wording as follows: Keep the container tightly closed.
6.5 Nature and Contents of Container
Include statement: Not all pack sizes may be marketed.
10. Date of revision of text
April 2007
Updated on 18 November 2004
Reasons for updating
- New PIL for medicines.ie
Updated on 20 August 2003
Reasons for updating
- Improved electronic presentation
Legal category:Supply through general sale
Updated on 19 August 2003
Reasons for updating
- Improved electronic presentation
Legal category:Supply through general sale
Updated on 12 August 2003
Reasons for updating
- Improved electronic presentation
Legal category:Supply through general sale
Updated on 25 June 2003
Reasons for updating
- New SPC for medicines.ie
Legal category:Supply through general sale
Haleon Ireland Limited
Address:
12 Riverwalk, Citywest Business Campus, Dublin 24, IrelandMedical Information Direct Line:
1800 441 442